13F HOLDINGS REPORT
ARCH Venture Management, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001012975-25-000787
Total Value
$492.4M
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | RAPPORT THERAPEUTICS INC. | RAPP | 3,728,738 | $110.7M | 22.49% |
| 2 | BEAM THERAPEUTICS INC. | BEAM | 4,540,132 | $110.2M | 22.38% |
| 3 | MAZE THERAPEUTICS INC. | MAZE | 4,120,053 | $106.8M | 21.70% |
| 4 | VIR BIOTECHNOLOGY INC. | VIR | 12,916,663 | $73.8M | 14.98% |
| 5 | LYELL IMMUNOPHARMA INC. | LYEL | 2,759,072 | $44.8M | 9.10% |
| 6 | ERASCA INC. | ERAS | 11,055,554 | $24.1M | 4.89% |
| 7 | GOSSAMER BIO INC. | GOSS | 8,055,916 | $21.2M | 4.30% |
| 8 | Q32 BIO INC. | QTTB | 320,482 | $634,554 | 0.13% |
| 9 | CERO THERAPEUTICS HOLDINGS INC. | CEROW | 22,389 | $113,960 | 0.02% |